Latest News and Press Releases

BOTHELL, WA--(Marketwired - Nov 17, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that it...

BOTHELL, WA--(Marketwired - Nov 16, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported financial...

BOTHELL, WA--(Marketwired - Nov 3, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its...

SHANGHAI, CHINA and BOTHELL, WA--(Marketwired - Sep 28, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases and...

BOTHELL, WA--(Marketwired - Aug 13, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...

BOTHELL, WA--(Marketwired - Aug 6, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the...

BOTHELL, WA--(Marketwired - Aug 5, 2015) - Marina Biotech, Inc. (OTCQB: MRNA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CEQ508, an...

BOTHELL, WA--(Marketwired - Jun 10, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the...

BOTHELL, WA--(Marketwired - May 14, 2015) -  Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...

BOTHELL, WA--(Marketwired - May 5, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that its...